Inactive

THIS IS A SOURCES SOUGHT ANNOUNCEMENT ONLY. It is neither a solicitation announcement nor a request for proposals or quotes and does not obligate the Government to award a contract. Requests for a sol... THIS IS A SOURCES SOUGHT ANNOUNCEMENT ONLY. It is neither a solicitation announcement nor a request for proposals or quotes and does not obligate the Government to award a contract. Requests for a solicitation will not receive a response. Responses to this source sought must be in writing. The purpose of this sources sought announcement is for market research to make appropriate acquisition decisions and to gain knowledge of potential qualified Small Businesses interested and capable of providing the services described below. The information gained from this market research will help the National Institutes, Clinical Center, Center for Cellular Engineering plan for its acquisition strategy. Potential Large and Small Businesses shall include business information outlined in the section below as a part of their response. Complete responses to this notice shall be in the following format: SAM UEI Number Company Name Company Address, City, State and Zip Code Company Point of Contact, Email Address and Telephone Number Current GSA Schedule appropriate to this Sources Sought Socioeconomic Status: (i.e., HUBZone, 8a, Small Business, Women Owned Small Business, Veteran-Owned Small-Business, etc.) as validated in Central Contractor Registration (CCR). All offerors must register in CCR located in https://www.sam.gov. Provide a capability statement that addresses the organizations qualifications and ability to perform as a contractor for the work described in the Statement of Work. POTS: 25-002531 ***************************************************************************** The National Institutes of Health, Clinical Center, Center for Cellular Engineering (CCE) has a need for Agilent BioTek Synergy H1 Hybrid Multi-Mode Reader, Model H1M. The Center for Cellular Engineering manufactures cell and gene therapies for Clinical Trials Phase I and II; processes hematopoietic stem cell grafts for transplantation; develops new cell therapies; performs in-process and lot release testing of cell and gene therapies; develops new assays to test cell and gene therapies; prepares chemistry, manufacturing, and controls (CMC) documents for investigational new drugs (IND) and summary data for annual reports to the Food and Drug Administration. The new Agilent BioTek Synergy H1 Hybrid Multi-Mode Reader will save run time and reduce cost for each lot release /potency assay. This is extremely import for clinical cell and gene therapeutic products manufactured with limited cell number for the potency assays. NAICS: 339113 - Surgical Appliance and Supplies Manufacturing PSC: 6640- Laboratory Equipment and Supplies Product Description: Catalog Number: 11120533 Vendor Catalog # SH1M-SN Description Tek Synergy H1 Hybrid Multimode Reader, Model: H1M. Incubator Temperature: 4-Zone incubation to 45 degrees C. Includes: Monochromator fluorescence; Monochromator absorbance; Full-light luminescence; Time resolved fluorescence. To include Delivery, Installation, Training and Gen5 Medical. Quantity 1 Period of Performance: ARO 15 Days Delivery Location: Deliver to: Attention: TBD National Institutes of Health 10 Center Drive Building 10, Room TBD Bethesda, MD 20892-1288 Contractors shall not reach out to the customer for any questions or clarifications. All communications must go through contracting. ****************************************************************************** Important information: The Government is not obligated to, nor will it pay for or reimburse any costs associated with responding to this source sought synopsis request. This notice shall not be construed as a commitment by the Government to issue a solicitation or ultimately award a contract, nor does it restrict the Government to a particular acquisition approach. The Government will in no way be bound to this information if any solicitation is issued. No sub-contracting opportunity is anticipated. Notice to potential offerors: All offerors who provide goods or services to the United States Federal Government must be registered and have an active registration in the System for Award Management (SAM) at www.sam.gov and complete Online Representations and Certifications Application (ORCA). All interested Offerors should submit information by e-mail to, referencing this posting number 25-002531, may be submitted to the Clinical Center, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, electronically to the attention of Emeka Onyejekwe, Contract Specialist, at Emeka.onyejekwe@nih.gov by the due date and time marked in this notice. All information submissions shall be received no later than 12:00 pm Eastern Standard Time, January 17, 2025.